Antioxidants in Kidney Diseases: The Impact of Bardoxolone Methyl

Tesauro, M., Canale, M. P., Rodia, G., Daniele, N. D., Lauro, D., Scuteri, A., & Cardillo, C. (2011). Metabolic Syndrome, Chronic Kidney, and Cardiovascular Diseases: Role of Adipokines. Cardiology Research and Practice, 2011(), 585-595-081. https://doi.org/10.4061/2011/653182
Kuo, K. L., & Tarng, D. C. (2010). Oxidative Stress in Chronic Kidney Disease. Adaptive Medicine, 2(2), 87-94. https://doi.org/10.4247/AM.2010.ABA010
林柏松、劉品秀、郭芳娟、吳再坤、陳昶旭、白美安、王雪芳（2015）。Metabolic Syndrome and Renal Function of the Chronic Kidney Disease Patients。臺灣營養學會雜誌，40(4)，122-135。https://doi.org/10.6691/NSJ.201512_40(4).0001
黃瓊瑩、黃政文、洪冠予（2018）。Pharmacological and Non-Pharmacological Treatment of Diabetic Kidney Disease。腎臟與透析，30(3)，123-127。https://doi.org/10.6340/KD.201809_30(3).0005
余志恆、劉冠宏、張育誌、宋俊明（2019）。Pathophysiological Mechanism of Anemia in Chronic Kidney Disease。腎臟與透析，31(4)，161-166。https://doi.org/10.6340/KD.201912_31(4).0001